Recall Radar
All recallsMedicine & devices

Niacin Extended-release Tablets, USP, 1,000 mg, 90-count bottles, Rx Only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC 62175-322-46.

Failed Dissolution Specifications: during 12M LT stability testing OOS low for Stage 3 dissolution at the 24-hour timepoint.

Class II Medicine & devices FDA June 10, 2026 Reached Texas
Read the official FDA notice →

What to do

Stop using the product and check it against the description above. Follow the remedy on the official notice; most recalls are refunded or replaced without a receipt. If you or a family member has already been affected, keep the packaging and the lot code — they're what a claim rests on later.

Details

Recalling company
Lannett Company Inc. — Seymour, IN
Severity
Class II — moderate
Reported
June 10, 2026
Quantity
3984 bottles
Recall number
D-0584-2026
Status
Ongoing
Source
FDA

Where it went

Nationwide within the United States

Other medicine & devices recalls

See every current recall on the live dashboard →